Transient vision loss is a temporary loss of vision that lasts from seconds to minutes and then fully recovers. It can be a warning sign of serious conditions like Transient Ischemic Attack and should not be ignored.
Temporary or transient vision loss is frightening, but also confusing. Read on to understand the reasons for the same, says Dr Bhartiya.
Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.
Migraine Aura vs TIA: How to Tell the Difference
Some episodes are harmless migraine aura. Others are warning signs of stroke.
Because symptoms can overlap, many patients are reassured when they should be evaluated, or alarmed unnecessarily. Understanding the pattern matters.
1️⃣ What Is Transient Vision Loss?
Transient vision loss means vision becomes blurred, dim, or missing for seconds to minutes, then returns.
It may affect:
- One eye
- Part of vision
- Both eyes
The pattern helps identify the cause.
2️⃣ Migraine Visual Aura
Migraine with aura
Migraine aura is caused by temporary changes in brain electrical activity.
Typical features:
- Gradual onset
- Expanding zig-zag lights or shimmering edges
- Blind spots that move
- Duration 20–40 minutes
- Often followed by headache
- Occurs in younger patients
Vision usually returns completely.
This is usually benign.
But pattern consistency matters.
3️⃣ TIA or Amaurosis Fugax
Transient ischemic attack
Amaurosis fugax
A transient ischemic attack is a brief interruption of blood flow.
When it affects vision, patients may describe:
- Sudden dark curtain over one eye
- Vision fading or dimming
- Loss lasting seconds to minutes
- No shimmering lights
- Often older age or vascular risk
This is a warning sign of stroke.
It requires urgent evaluation.
4️⃣ Key Differences at a Glance
| Feature | Migraine Aura | TIA / Amaurosis Fugax |
|---|---|---|
| Onset | Gradual | Sudden |
| Visual pattern | Shimmering zig-zags | Dark curtain |
| Duration | 20–40 min | Seconds–minutes |
| Age group | Younger | Older / vascular risk |
| After-effect | Headache common | Weakness or speech change possible |
Patterns are more important than isolated episodes.
5️⃣ Why Misdiagnosis Happens
Because:
- Migraine aura can occur without headache
- TIA may be painless
- Symptoms may resolve before testing
- Routine eye exams may look normal
Diagnosis requires careful history, not just tests.
6️⃣ Warning Signs That Need Urgent Care
Seek urgent evaluation if you have:
- First-ever transient vision loss
- Sudden dark curtain over one eye
- Vision loss with weakness or speech change
- New symptoms after age 40
- Diabetes, hypertension, or smoking history
Even if vision returns, the risk may remain.
7️⃣ Why Early Evaluation Matters
Because a TIA is often a warning stroke.
Early detection allows:
- Stroke prevention
- Carotid artery evaluation
- Blood pressure control
- Medication initiation
Waiting may lead to permanent vision or brain injury.
8️⃣ What Evaluation May Include
- Detailed visual history
- Eye examination
- Visual field testing
- OCT
- Carotid Doppler
- MRI / brain imaging
- Neurology referral
The goal is to identify risk early.
Appointment Information
For neuro-ophthalmology evaluation or structured second opinion:
🌐 drshibalbhartiya.com
📞 +91 88826 38735
Please bring:
- Previous eye reports
- MRI/CT scans
- Medication list
- Blood pressure and sugar records
Seeing clearly is not the same as seeing safely.
Read the research articles
Read the research articles
This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine. This article was updated in April 2026.
She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.
As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.
Access her work on Pubmed, Google Scholar, ResearchGate and ORCID.
Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care
www.drshibalbhartiya.com
+91 88826 38735
1500+ Five Star Patient Reviews Google Business Profile
Upload your reports for a structured review.
If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma